1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.4 YEARS CONSIDERED FOR THE STUDY 19
1.5 LIMITATIONS 19
1.6 CURRENCY 19
1.7 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH APPROACH 20
2.2 MARKET SIZE ESTIMATION 22
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3.1 DATA FROM SECONDARY SOURCES 25
2.3.2 DATA FROM PRIMARY SOURCES 25
2.3.3 KEY INDUSTRY INSIGHTS 26
2.4 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 32
4.1 HIGH-CONTENT SCREENING: MARKET SNAPSHOT 32
4.2 EUROPE: HIGH-CONTENT SCREENING MARKET, BY APPLICATION (2016) 33
4.3 GEOGRAPHIC SNAPSHOT OF THE HIGH-CONTENT SCREENING MARKET 34
4.4 HIGH-CONTENT SCREENING MARKET: REGIONAL MIX 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 KEY MARKET DYNAMICS 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Need for cost containment in pharmaceutical R&D 38
5.2.1.2 Government funding and venture capital investments across developed markets 39
5.2.1.3 Advancements in informatics solutions and imaging instruments 39
5.2.2 MARKET RESTRAINTS 40
5.2.2.1 Lower adoption of HCS instruments due to their high prices 40
?
5.2.3 MARKET OPPORTUNITIES 41
5.2.3.1 Increasing number of CROs providing HCS services 41
5.2.3.2 Application of HCS in personalized medicine 41
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Dearth of knowledgeable and skilled operators of HCS instruments 42
5.2.4.2 Inadequate infrastructure and funding for R&D in emerging countries 42

6 INDUSTRY INSIGHTS 44
6.1 INDUSTRY TRENDS 44
6.1.1 RISING ADOPTION OF LABEL-FREE TECHNOLOGIES 44
6.1.2 GROWING FOCUS ON STEM CELL ANALYSIS 44
6.2 TECHNOLOGICAL ROADMAP 45

7 GLOBAL HIGH-CONTENT SCREENING MARKET, BY PRODUCT 47
7.1 INTRODUCTION 48
7.2 INSTRUMENTS 49
7.2.1 CELL IMAGING AND ANALYSIS SYSTEMS 51
7.2.2 FLOW CYTOMETERS 52
7.2.2.1 Cell analyzers 54
7.2.2.2 Cell sorters 55
7.3 CONSUMABLES 56
7.3.1 REAGENTS & ASSAY KITS 57
7.3.2 MICROPLATES 58
7.3.3 OTHER CONSUMABLES 59
7.4 SOFTWARE 60
7.5 SERVICES 61
7.6 ACCESSORIES 62

8 GLOBAL HIGH-CONTENT SCREENING MARKET, BY APPLICATION 63
8.1 INTRODUCTION 64
8.2 PRIMARY AND SECONDARY SCREENING 65
8.3 TARGET IDENTIFICATION AND VALIDATION 66
8.4 TOXICITY STUDIES 67
8.5 COMPOUND PROFILING 68
8.6 OTHER APPLICATIONS 69

9 GLOBAL HIGH-CONTENT SCREENING MARKET, BY END USER 70
9.1 INTRODUCTION 71
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 72
9.3 ACADEMIC AND GOVERNMENT INSTITUTES 73
9.4 CONTRACT RESEARCH ORGANIZATIONS 74
?

10 HIGH-CONTENT SCREENING MARKET, BY REGION 75
10.1 INTRODUCTION 76
10.2 NORTH AMERICA 78
10.2.1 U.S. 81
10.2.2 CANADA 83
10.3 EUROPE 85
10.3.1 GERMANY 89
10.3.2 U.K. 91
10.3.3 FRANCE 93
10.3.4 SWITZERLAND 95
10.3.5 REST OF EUROPE 97
10.4 ASIA-PACIFIC 99
10.4.1 JAPAN 103
10.4.2 CHINA 105
10.4.3 INDIA 107
10.4.4 REST OF ASIA-PACIFIC 109
10.5 LATIN AMERICA 112
10.6 MIDDLE EAST AND AFRICA 114

11 COMPETITIVE LANDSCAPE 117
11.1 OVERVIEW 117
11.2 COMPETITIVE ANALYSIS 118
11.2.1 MARKET PLAYERS RANKING 118
11.2.2 PRODUCT MATRIX 120
11.2.3 VENDOR BENCHMARKING 121
11.3 COMPETITIVE SITUATIONS AND TRENDS 123
11.3.1 PRODUCT LAUNCHES 124
11.3.2 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 125
11.3.3 ACQUISITIONS 126
11.3.4 EXPANSIONS 127

12 COMPANY PROFILES 128
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 INTRODUCTION 128
12.2 GE HEALTHCARE 129
12.3 DANAHER CORPORATION 132
12.4 PERKINELMER, INC. 135
12.5 THERMO FISHER SCIENTIFIC INC. 138
12.6 BECTON, DICKINSON AND COMPANY 141
12.7 BIOTEK INSTRUMENTS, INC. 144
12.8 BIO-RAD LABORATORIES, INC. 146
12.9 TECAN GROUP LTD. 148
12.10 YOKOGAWA ELECTRIC CORPORATION 150
12.11 MERCK MILLIPORE 152
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13 APPENDIX 154
13.1 INSIGHTS OF INDUSTRY EXPERTS 154
13.2 DISCUSSION GUIDE 155
13.3 OTHER DEVELOPMENTS 158
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 162
13.6 AVAILABLE CUSTOMIZATIONS 164
13.7 RELATED REPORTS 165
13.8 AUTHOR DETAILS 166